Superiority of TB-PCR Over Conventional and Immunologic Tests for Diagnosing Tuberculosis in Small Bronchoscopic Non-Malignant Specimens
Infection and Drug Resistance · 2025-12 · Volume 18 · 6491-6500
DOI: 10.2147/idr.s558492 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection and Drug Resistance, 2025-12. Verfasst von Fei Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Pulmonology and Endoscopic Diagnosis and Treatment Center, Anhui Chest Hospital, Hefei, Anhui, 230022, People's Republic…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
In the small non-malignant specimens acquired through respiratory endoscopy, the conventional pathological examination approaches such as acid-fast staining have certain restrictions in the sensitivity of tuberculosis diagnosis.
Objective
To investigate the sensitizing effect and clinical value of polymerase chain reaction for Mycobacterium tuberculosis (TB-PCR) based on fluorescent probe nucleic acid detection technology in improving the diagnostic positive rate of non-malignant small specimens obtained by respiratory endoscopy.
Methods
A retrospective analysis was conducted on 729 patients with suspected TB who underwent respiratory endoscopy. All patients provided small non-malignant specimens for TB-PCR, acid-fast staining, and mycobacterial culture. A clinical composite diagnosis served as the gold standard. Diagnostic performance was assessed by accuracy, sensitivity, specificity, and area under the ROC curve (AUC). A subgroup of 113 patients underwent additional testing (T-SPOT. TB, TB-Ab, BALF-G-Xpert, BALF-TB) for extended comparison.
Results
The AUC, accuracy, sensitivity, specificity, PPV and NPV of TB-PCR in the diagnosis of TB were 0.88 (95% CI: 0.86-0.90), 0.88 (95% CI: 0.85-0.90), 0.99 (95% CI: 0.98-1.00), 0.78 (0.74-0.82), 0.79 (95% CI: 0.75-0.83), 0.99 (95% CI: 0.97-1.00), respectively. Among 729 patients (391 TB+, 338 TB-), TB-PCR showed significantly higher overall diagnostic efficacy (AUC: 0.88) than acid-fast staining (AUC: 0.77, P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Interventional Pulmonology and Endoscopic Diagnosis and Treatment Center, Anhui Chest Hospital, Hefei, Anhui, 230022, People's Republic of China.
- Department of Pathology Department, Anhui Chest Hospital, Hefei, Anhui, 230022, People's Republic of China.
Zitieren
APA
Tang, F., Zha, X., Zhao, J., Ye, W., Lv, L., & Ma, D. (2025). Superiority of TB-PCR Over Conventional and Immunologic Tests for Diagnosing Tuberculosis in Small Bronchoscopic Non-Malignant Specimens. Infection and Drug Resistance, Volume 18, 6491-6500. https://doi.org/10.2147/idr.s558492
Vancouver
Tang F, Zha X, Zhao J, Ye W, Lv L, Ma D. Superiority of TB-PCR Over Conventional and Immunologic Tests for Diagnosing Tuberculosis in Small Bronchoscopic Non-Malignant Specimens. Infection and Drug Resistance. 2025;Volume 18:6491-6500. doi:10.2147/idr.s558492
BibTeX
@article{Tang2025,
author = {Tang, Fei and Zha, Xiankui and Zhao, Jieting and Ye, Wei and Lv, Liping and Ma, Dongchun},
title = {Superiority of TB-PCR Over Conventional and Immunologic Tests for Diagnosing Tuberculosis in Small Bronchoscopic Non-Malignant Specimens},
journal = {Infection and Drug Resistance},
year = {2025},
volume = {Volume 18},
pages = {6491--6500},
doi = {10.2147/idr.s558492}
}
EUVIMED